Status:
COMPLETED
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients
Lead Sponsor:
University of Cologne
Collaborating Sponsors:
German Center for Infection Research
Conditions:
CKD (Chronic Kidney Disease) Stage 5D
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The investigators compare two strata of vaccinated patients: those recently vaccinated and those vaccinated more than two years ago. The primary objective is to compare pneumonia rates between the gro...
Detailed Description
Participating sites will screen all hemodialysis patients at their outpatient dialysis clinic for eligibility. Eligible patients will be approached and informed by their treating physician. If a patie...
Eligibility Criteria
Inclusion
- Signed informed consent form including enrolment in registry database (QiN-registry)
- Patients with stage 5 chronic kidney disease treated with chronic hemodialysis
- Patients who are either already vaccinated or eligible and willing to be vaccinated against pneumococcal infection in accordance with current STIKO recommendations
- Age of 18 years or older
Exclusion
- Patients unwilling/ineligible for vaccination under current STIKO recommendations
Key Trial Info
Start Date :
December 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
792 Patients enrolled
Trial Details
Trial ID
NCT03350425
Start Date
December 21 2017
End Date
December 31 2022
Last Update
December 16 2024
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Eberhard Karls University Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72074
2
Hospital of the Ludwig-Maximilians-University (LMU)
Munich, Bavaria, Germany, 80336
3
The University Hospital Klinikum rechts der Isar - MRI TUM
Munich, Bavaria, Germany, 81675
4
University Hospital Giessen und Marburg, Giessen site
Giessen, Hesse, Germany, 35392